The Growing Importance of Real World Data

PharmaExec.com
January 2017
Author: Dr. Chitra Lele, Sciformix Corporation

As the life sciences market continues to evolve where payers and patients are playing a more integral role in the landscape, organizations are placing greater focus on how they plan for commercialization much earlier in the development process. Companies must provide evidence and demonstrate the value of products to multiple stakeholders. Real World Evidence (RWE) and Market Access (MA) are inherent to reach this goal and increasingly crucial to ensure patient access and commercial success.

Read the full story here.